Atherosclerosis
Издатель: Elsevier · ISSN 0021-9150 · 50 статей
- The association between remnant cholesterol levels and cognitive impairment and dementia: evidence from epidemiological studies
- Proteomic Characterisation of Balloon-Adherent Material after Superior Mesenteric Artery Revascularisation in Chronic Mesenteric Ischaemia
- Aortic Stenosis in Familial Hypercholesterolemia: A Meta-Analysis
- Prognostic implications of angiography-derived radial wall strain in physiologically deferred non-flow limiting coronary lesions
- Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis
- A novel small-molecule inhibitor of proteoglycan GAG-chain elongation that alone or in combination with rosuvastatin inhibits lipid deposition in the aortic walls of high-fat fed ApoE-/- mice
- Lipoprotein(a) and incident peripheral artery disease in the Atherosclerosis Risk in Communities Study
- Soluble JAM-A enhances platelet activation through facilitation of homodimer formation and worsens atherosclerosis prognosis
- Monounsaturated Fatty Acids in Adipose Tissue and the Risk of Peripheral Artery Disease: A Danish Case-Cohort study
- Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832
- Cumulative LDL cholesterol exposure after percutaneous coronary intervention is associated with major adverse cardiovascular events
- Beyond a single measurement: the role of cumulative LDL-C exposure after percutaneous coronary intervention
- Prognostic Value of 13N-Ammonia PET–Derived Myocardial Flow Reserve and Its Association With Peripheral Arterial Flow Impairment and Aortic Stiffness in Hemodialysis Patients
- Non-HDL cholesterol as a lipid control target in severe hypercholesterolemia in primary care: a sex-stratified analysis
- Editorial Board
- What does focal coronary imaging tell us about the whole patient?
- Lp(a) reduction with PCSK9 inhibitors: How does real-world data stack up?
- Lysosomal dysfunction in vascular smooth muscle cells: Mechanisms and therapeutic targets in vascular disease
- ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis
- Functional data for LDLR variant classification: comparative insights from high-content microscopy and flow cytometry assays
- Macrophage-derived TNF-α promotes vascular inflammation and cell crosstalk in human atherosclerotic plaques via TNFRSF1A
- PlGF modulates vascular smooth muscle cells phenotype to enhance atherosclerotic plaque stability
- Immune-inflammatory profiles, coronary artery disease, and peripheral artery disease in people with HIV
- Relationship of atherosclerotic lesion by optical coherence tomography with cholesterol efflux capacity by immobilized liposome-bound gel beads method
- Lipoprotein(a) in acute myocardial infarction – insights from the randomised ASSAIL-MI trial
- Sex-specific differences in acute coronary syndrome management and outcomes: How age and treatment gaps mask a female survival advantage
- Lipoprotein(a) reduction with PCSK9-targeting pharmacotherapy: A prospective real-world registry study
- Inflammation and lipoprotein(a) as predictors of cardiovascular events across baseline risk levels – results from the UK Biobank
- Association of beta-blocker therapy with outcomes after ST-segment elevation myocardial infarction stratified by GRACE risk score: A nationwide registry analysis
- Development and external validation of a non-laboratory model to predict early-onset cardiovascular disease risk: a multicohort machine learning study